Trial Profile
Analysis of serum epithelium mesenchymal system marker for advanced or metastatic breast cancer treated with Eribulin
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2021
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Pharmacodynamics
- 03 Jul 2017 New trial record